Treatment of keratosis pilaris and its variants: a systematic review
- PMID: 32886029
- DOI: 10.1080/09546634.2020.1818678
Treatment of keratosis pilaris and its variants: a systematic review
Abstract
Introduction: Keratosis pilaris (KP) is a common, benign skin condition of follicular hyperkeratosis. Although KP is asymptomatic, the cosmetic appearance of KP can lead to psychosocial distress among patients. New emerging treatments are increasingly being utilized. Yet, there is little to no summative data on the treatments of KP and its subtypes.
Objective: To summarize existing literature on treatments for KP and its subtypes.
Methods: A comprehensive search was performed using Pubmed/MEDLINE, Embase and Web of Science databases. The search identified 1150 non-duplicated articles, and 47 articles were included in the review. The primary outcomes measured were KP treatment type and the degree of improvement following therapy.
Findings: Our findings demonstrate that the most supported form of treatment for KP is laser therapy, particularly the QS:Nd YAG laser. Topical treatments - including Mineral Oil-Hydrophil Petrolat, tacrolimus, azelaic acid, and salicylic acid - are also effective at least for improving the appearance of KP.
Conclusion: While the measured treatment outcomes varied among studies, laser therapy appears to be the most effective form of treatment. Use of topicals also improved KP lesions.
Keywords: Keratosis pilaris; keratosis pilaris atrophicans; laser therapy; skin of color.
Similar articles
-
Keratosis pilaris: an update and approach to management.Ital J Dermatol Venerol. 2023 Jun;158(3):217-223. doi: 10.23736/S2784-8671.23.07594-1. Epub 2023 May 11. Ital J Dermatol Venerol. 2023. PMID: 37166753 Review.
-
Light and Laser Treatments for Keratosis Pilaris: A Systematic Review.Dermatol Surg. 2020 Nov;46(11):1397-1402. doi: 10.1097/DSS.0000000000002441. Dermatol Surg. 2020. PMID: 32804891
-
Innovative 1064-nm Nd:YAG Laser Significantly Improves Keratosis Pilaris, A Randomized, Double-Blind, Sham-Irradiation-Controlled Trial.Lasers Surg Med. 2020 Jul;52(6):509-514. doi: 10.1002/lsm.23184. Epub 2019 Nov 11. Lasers Surg Med. 2020. PMID: 31713266 Clinical Trial.
-
Keratosis Pilaris and its Subtypes: Associations, New Molecular and Pharmacologic Etiologies, and Therapeutic Options.Am J Clin Dermatol. 2018 Oct;19(5):733-757. doi: 10.1007/s40257-018-0368-3. Am J Clin Dermatol. 2018. PMID: 30043128 Review.
-
Treatment of pigmented keratosis pilaris in Asian patients with a novel Q-switched Nd:YAG laser.J Cosmet Laser Ther. 2011 Jun;13(3):120-2. doi: 10.3109/14764172.2011.581290. J Cosmet Laser Ther. 2011. PMID: 21609214 Clinical Trial.
Cited by
-
A Review of the Scoring and Assessment of Keratosis Pilaris.Skin Appendage Disord. 2023 Aug;9(4):241-251. doi: 10.1159/000529487. Epub 2023 Apr 20. Skin Appendage Disord. 2023. PMID: 37564689 Review.
-
The Crucial Roles and Research Advances of cGAS-STING Pathway in Cutaneous Disorders.Inflammation. 2023 Aug;46(4):1161-1176. doi: 10.1007/s10753-023-01812-7. Epub 2023 Apr 21. Inflammation. 2023. PMID: 37083899 Free PMC article. Review.
-
A Narrative Review on the Role of Acids, Steroids, and Kinase Inhibitors in the Treatment of Keratosis Pilaris.Cureus. 2021 Oct 20;13(10):e18917. doi: 10.7759/cureus.18917. eCollection 2021 Oct. Cureus. 2021. PMID: 34692268 Free PMC article. Review.
Publication types
MeSH terms
Supplementary concepts
LinkOut - more resources
Full Text Sources